Identification of the α2-δ-1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

Mark J. Field, Peter J. Cox, Emma Stott, Heather L Melrose, James Offord, Ti Zhi Su, Steve Bramwell, Laura Corradini, Steven England, Joanna Winks, Ross A. Kinloch, Jan Hendrich, Annette C. Dolphin, Tony Webbl, Dic Williams

Research output: Contribution to journalArticle

391 Citations (Scopus)

Abstract

Neuropathic pain is a debilitating condition affecting millions of people around the world and is defined as pain that follows a lesion or dysfunction of the nervous system. This type of pain is difficult to treat, but the novel compounds pregabalin (Lyrica) and gabapentin (Neurontin) have proven clinical efficacy. Unlike traditional analgesics such as nonsteroidal antiinflammatory drugs or narcotics, these agents have no frank antiinflammatory actions and no effect on physiological pain. Although extensive preclinical studies have led to a number of suggestions, until recently their mechanism of action has not been clearly defined. Here, we describe studies on the analgesic effects of pregabalin in a mutant mouse containing a single-point mutation within the gene encoding a specific auxiliary subunit protein (α2-δ-1) of voltage-dependent calcium channels. The mice demonstrate normal pain phenotypes and typical responses to other analgesic drugs. We show that the mutation leads to a significant reduction in the binding affinity of pregabalin in the brain and spinal cord and the loss of its analgesic efficacy. These studies show conclusively that the analgesic actions of pregabalin are mediated through the α2-8-1 subunit of voltage-gated calcium channels and establish this subunit as a therapeutic target for pain control.

Original languageEnglish (US)
Pages (from-to)17537-17542
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume103
Issue number46
DOIs
StatePublished - Nov 14 2006

Fingerprint

Calcium Channels
Analgesics
Calcium
Pain
Anti-Inflammatory Agents
Narcotics
Protein Subunits
Neuralgia
Point Mutation
Nervous System
Spinal Cord
Pregabalin
Phenotype
Mutation
Brain
Pharmaceutical Preparations
Genes
gabapentin

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Identification of the α2-δ-1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. / Field, Mark J.; Cox, Peter J.; Stott, Emma; Melrose, Heather L; Offord, James; Su, Ti Zhi; Bramwell, Steve; Corradini, Laura; England, Steven; Winks, Joanna; Kinloch, Ross A.; Hendrich, Jan; Dolphin, Annette C.; Webbl, Tony; Williams, Dic.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, No. 46, 14.11.2006, p. 17537-17542.

Research output: Contribution to journalArticle

Field, MJ, Cox, PJ, Stott, E, Melrose, HL, Offord, J, Su, TZ, Bramwell, S, Corradini, L, England, S, Winks, J, Kinloch, RA, Hendrich, J, Dolphin, AC, Webbl, T & Williams, D 2006, 'Identification of the α2-δ-1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin', Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17537-17542. https://doi.org/10.1073/pnas.0409066103
Field, Mark J. ; Cox, Peter J. ; Stott, Emma ; Melrose, Heather L ; Offord, James ; Su, Ti Zhi ; Bramwell, Steve ; Corradini, Laura ; England, Steven ; Winks, Joanna ; Kinloch, Ross A. ; Hendrich, Jan ; Dolphin, Annette C. ; Webbl, Tony ; Williams, Dic. / Identification of the α2-δ-1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. In: Proceedings of the National Academy of Sciences of the United States of America. 2006 ; Vol. 103, No. 46. pp. 17537-17542.
@article{d478485f63d1406194031f59d4720733,
title = "Identification of the α2-δ-1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin",
abstract = "Neuropathic pain is a debilitating condition affecting millions of people around the world and is defined as pain that follows a lesion or dysfunction of the nervous system. This type of pain is difficult to treat, but the novel compounds pregabalin (Lyrica) and gabapentin (Neurontin) have proven clinical efficacy. Unlike traditional analgesics such as nonsteroidal antiinflammatory drugs or narcotics, these agents have no frank antiinflammatory actions and no effect on physiological pain. Although extensive preclinical studies have led to a number of suggestions, until recently their mechanism of action has not been clearly defined. Here, we describe studies on the analgesic effects of pregabalin in a mutant mouse containing a single-point mutation within the gene encoding a specific auxiliary subunit protein (α2-δ-1) of voltage-dependent calcium channels. The mice demonstrate normal pain phenotypes and typical responses to other analgesic drugs. We show that the mutation leads to a significant reduction in the binding affinity of pregabalin in the brain and spinal cord and the loss of its analgesic efficacy. These studies show conclusively that the analgesic actions of pregabalin are mediated through the α2-8-1 subunit of voltage-gated calcium channels and establish this subunit as a therapeutic target for pain control.",
author = "Field, {Mark J.} and Cox, {Peter J.} and Emma Stott and Melrose, {Heather L} and James Offord and Su, {Ti Zhi} and Steve Bramwell and Laura Corradini and Steven England and Joanna Winks and Kinloch, {Ross A.} and Jan Hendrich and Dolphin, {Annette C.} and Tony Webbl and Dic Williams",
year = "2006",
month = "11",
day = "14",
doi = "10.1073/pnas.0409066103",
language = "English (US)",
volume = "103",
pages = "17537--17542",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "46",

}

TY - JOUR

T1 - Identification of the α2-δ-1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

AU - Field, Mark J.

AU - Cox, Peter J.

AU - Stott, Emma

AU - Melrose, Heather L

AU - Offord, James

AU - Su, Ti Zhi

AU - Bramwell, Steve

AU - Corradini, Laura

AU - England, Steven

AU - Winks, Joanna

AU - Kinloch, Ross A.

AU - Hendrich, Jan

AU - Dolphin, Annette C.

AU - Webbl, Tony

AU - Williams, Dic

PY - 2006/11/14

Y1 - 2006/11/14

N2 - Neuropathic pain is a debilitating condition affecting millions of people around the world and is defined as pain that follows a lesion or dysfunction of the nervous system. This type of pain is difficult to treat, but the novel compounds pregabalin (Lyrica) and gabapentin (Neurontin) have proven clinical efficacy. Unlike traditional analgesics such as nonsteroidal antiinflammatory drugs or narcotics, these agents have no frank antiinflammatory actions and no effect on physiological pain. Although extensive preclinical studies have led to a number of suggestions, until recently their mechanism of action has not been clearly defined. Here, we describe studies on the analgesic effects of pregabalin in a mutant mouse containing a single-point mutation within the gene encoding a specific auxiliary subunit protein (α2-δ-1) of voltage-dependent calcium channels. The mice demonstrate normal pain phenotypes and typical responses to other analgesic drugs. We show that the mutation leads to a significant reduction in the binding affinity of pregabalin in the brain and spinal cord and the loss of its analgesic efficacy. These studies show conclusively that the analgesic actions of pregabalin are mediated through the α2-8-1 subunit of voltage-gated calcium channels and establish this subunit as a therapeutic target for pain control.

AB - Neuropathic pain is a debilitating condition affecting millions of people around the world and is defined as pain that follows a lesion or dysfunction of the nervous system. This type of pain is difficult to treat, but the novel compounds pregabalin (Lyrica) and gabapentin (Neurontin) have proven clinical efficacy. Unlike traditional analgesics such as nonsteroidal antiinflammatory drugs or narcotics, these agents have no frank antiinflammatory actions and no effect on physiological pain. Although extensive preclinical studies have led to a number of suggestions, until recently their mechanism of action has not been clearly defined. Here, we describe studies on the analgesic effects of pregabalin in a mutant mouse containing a single-point mutation within the gene encoding a specific auxiliary subunit protein (α2-δ-1) of voltage-dependent calcium channels. The mice demonstrate normal pain phenotypes and typical responses to other analgesic drugs. We show that the mutation leads to a significant reduction in the binding affinity of pregabalin in the brain and spinal cord and the loss of its analgesic efficacy. These studies show conclusively that the analgesic actions of pregabalin are mediated through the α2-8-1 subunit of voltage-gated calcium channels and establish this subunit as a therapeutic target for pain control.

UR - http://www.scopus.com/inward/record.url?scp=33751232667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751232667&partnerID=8YFLogxK

U2 - 10.1073/pnas.0409066103

DO - 10.1073/pnas.0409066103

M3 - Article

C2 - 17088553

AN - SCOPUS:33751232667

VL - 103

SP - 17537

EP - 17542

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 46

ER -